Skip to content

Medical Devices; Radiology Devices; Classification of the Radiology Software for Referral of Findings Related to Fibrotic Lung Disease

Final rule · Federal Register document 2026-22180

Published
10/30/2026
Effective
10/30/2026
Pages
4

Summary

Final amendment; final order.

The Food and Drug Administration (FDA) is classifying the radiology software for referral of findings related to fibrotic lung disease into class II (special controls). The special controls that apply to the device type are identified in this order and will be part of the codified language for classification of the radiology software for referral of findings related to fibrotic lung disease. We are taking this action because we have determined that classifying the device into class II will provide a reasonable assurance of the safety and effectiveness of the device. We believe this action will also enhance patients' access to beneficial innovative devices, in part by reducing regulatory burdens.

Read the official textPDF on GovInfo

Details

Type
Final rule
Docket
Docket No. FDA-2026-N-12254
CFR parts
21 CFR 892
Topics
Medical devices, Radiation protection, X-rays

This page summarizes a Federal Register document. Only the official Federal Register text has legal effect. Comment deadlines can be extended or reopened by a later notice.

Source: Office of the Federal Register, via the Federal Register API · Last updated 10/30/2026

Share: